Healthcare
RVCF invests $2.8m in Frontier Lifeline
Rajasthan Venture Capital Fund (RVCF) has invested INR150 million ($2.8 million) for an 11% stake in Indian hospital Frontier Lifeline via a capital increase.
ChrysCapital no fair-weather friend to Intas
Back in 2005, the principal concern for much of India’s rural population was where their next meal was going to come from. Over the past seven years, however, the spoils of rapid economic growth have trickled down through the social strata. Rural residents...
India hospitals: Capital cure
Badly in need of consolidation and infrastructure investment, India’s hospital chains are an attractive target for private equity. But identifying suitable targets and getting them to scale up remains a challenge
Accel, IDG back Forus Health with $5m
Venture capital firms Accel Partners and IDG Ventures India have led a $5 million Series A round of funding for Indian medical technology company Forus Health.
Navis mulls buying Twilight Litaka stake
Malaysia-based Navis Capital Partners is in negotiations with Indian pharmaceutical company Twilight Litaka Pharma about a potential cash injection of $1.5 billion ($29 million) in the firm.
ChrysCapital reinvests $57m in Intas Pharmaceutical
ChrysCapital Partners is investing a further INR3 billion ($57 million) in Indian drugmaker Intas Pharmaceuticals ahead of the company’s upcoming initial public offering.
VC firms support Japan-US drug development alliance
Drais Pharmaceuticals, a US-based firm backed by InterWest Partners and Sutter Hill Ventures, will form a partnership with Japan’s Astellas Pharma to jointly develop a new line of drugs. Astellas has agreed to transfer assets to Drais-operated Telsar...
KKR takes 24% stake in China blood banker
It is a newborn child's first-ever insurance policy: Cord blood, rich in stem cells, is taken from the umbilical cord shortly after birth and placed into storage, only to be used if the child is later stricken by a serious illness. Cord blood can help...
KKR invests $65m in Chinese cord blood bank operator
KKR has agreed to invest $65 million into China Cord Blood Corporation (CCBC), the largest umbilical cord blood banking operator in China. It is the private equity firm’s first foray into the country’s fast-growing healthcare services industry. CCBC will...
Manipal Hospitals to raise $29m from private equity
Manipal Hospitals, India’s third largest healthcare group, is seeking as much as INR1.5 billion ($29 million) from private equity firms for a minority stake in order to fund expansion.
GIC, Baring invest $97m in India's Marico
Government of Singapore Investment Corp. (GIC) and Baring India Private Equity will purchase a 4.8% stake in Marico, the leading Indian manufacturer of personal care products, for INR5 billion ($97.7 million). The proceeds will partly be used to finance...
Advent International to invest $105m CARE Hospitals
Advent International will invest $105 million in multi-specialty hospital chain CARE Hospitals, representing its third investment in India.
TPG, Carlyle in talks for Fortis stake – report
TPG Capital India and The Carlyle Group are reportedly in talks to buy a 15-20% stake in Fortis Healthcare India, the listed chain of hospitals backed by Government of Singapore Investment Corp.
Mitsui Global Investment backs Belgian pharma firm
Mitsui Global Investment, a subsidiary of Japan's Mitsui & Co, has participated in a Series B round worth EUR23.6 million ($31.4 million) for Belgian pharmaceutical company Promethera Biosciences.
VC-backed Anaphore bolts on China's RuiYi
Anaphore, a US developer of protein pharmaceuticals backed by VC firms 5AM Ventures and Versant Ventures, has acquired Chinese biologics drug discovery platform RuiYi.
PE firms to invest in Super Religare Laboratories
Super Religare Laboratories (SRL), a pathology laboratory network in India, is likely to receive commitments from two private equity firms for its 15-20% stake sale.
GIC commits $100m to Indian eye-care chain
Already worth $40 billion and expected to double in size with compound annual growth of 21%, India’s healthcare market is certainly on the radar of private equity investors. Hospitals and treatment centers – a play on rising domestic consumption and perceived...
Blue Sky boosts Alcidion with $2.8m - report
Listed fund manager Blue Sky Alternative Investments has funneled A$2.6 million ($2.8 million) of capital into Australian health informatics firm Alcidion.
GIC commits $100m to Vasan Healthcare
Government of Singapore Investment Corp. (GIC) has invested $100 million for a minority stake in Vasan Healthcare, which runs eye care hospitals across India. The transaction is the largest PE deal in the country's healthcare industry since Olympus Capital’s...
India Venture Advisors backs drugs manufacturer
India Venture Advisors, the healthcare and life sciences-focused private equity fund founded by Ajay Piramal and former State Bank of India (SBI) chairman A K Purwar, has invested INR700 million ($13.8 million) in drug manufacturer Vardhman Chemtech....
PAG Asia bets $250m on Chinese pharmco
China is entering a new era, with its new model for growth powered by technology and innovation rather than a focus on cheap manufacturing. Biotechnology, as one of the seven “strategic emerging industries” in the 12th Five-Year plan, is experiencing...
EQT Partners invests in China Healthcare
EQT Partners has teamed up with the founder of China Healthcare and put in a cash offer to take the Singapore-listed company private. The deal values China Healthcare at S$80.4 million ($64 million).
CDH, CITIC, New Horizon buy Luye Pharma from MBK
CDH Capital, Citic Private Equity and New Horizon Capital, three of China's largest private equity firms, have bought Luye Pharma from Korea-based MBK Partners.
Osprey Medical plans to raise $20m in Australia listing
US-based Osprey Medical hopes to raise $20 million through a public listing in Australia next month. The medical device company submitted its prospectus to the stock exchange this week.